Craig-Hallum analyst Alexander Nowak lowered the firm’s price target on InfuSystem to $15 from $18 on near-term margins, while keeping a Buy rating on the shares. The firm notes InfuSystem delivered good Q3 results, exceeding revenue expectations and slightly raising sales guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on INFU:
